Screener
Phibro Animal Health PAHC Cash & Equivalents
Cash & Equivalents at other companies
Other financials
Where this comes from
Reported directly by Phibro Animal Health in its filing.
Tagged under the XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue.
The source filing: Phibro Animal Health’s 10-Q, filed May 6, 2026.
- Filed
- May 6, 2026, 4:25 PM EDT
- Fiscal quarter
- Q3 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001104659-26-056280
| As of | March 31, 2026 | June 30, 2025 |
|---|---|---|
| ASSETS | ||
| Cash and cash equivalents | $54,929 | $68,039 |
| Short-term investments | 22,522 | 9,000 |
| Accounts receivable, net | 221,546 | 227,983 |
| Inventories, net | 539,699 | 444,425 |
| Other current assets | 55,372 | 61,159 |
| Total current assets | 894,068 | 810,606 |
| Property, plant and equipment, net | 359,271 | 354,690 |
Item 1. Financial Statements (unaudited)
FAQ
- What is Phibro Animal Health's cash & equivalents?
- Phibro Animal Health (PAHC) reported cash & equivalents of $54.93M in Q1 2026.
- How has Phibro Animal Health's cash & equivalents changed year-over-year?
- Phibro Animal Health's cash & equivalents decreased by 9.0% year-over-year, from $60.35M to $54.93M.
- What is the long-term trend for Phibro Animal Health's cash & equivalents?
- Over 4 years (2021 to 2025), Phibro Animal Health's cash & equivalents has grown at a 7.9% compound annual growth rate (CAGR), from $50.21M to $68.04M.
- What does cash & equivalents mean?
- Cash on hand plus highly liquid investments with maturities of three months or less at purchase — treasury bills, money market funds, and commercial paper.
Ask your AI about Phibro Animal Health's cash & equivalents.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude